相关实验视频

Updated: Jul 23, 2025

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

在乳腺癌患者中循环瘤细胞的表征

GuoFen Lu, Hui Wu, DeKui Ma

Clinical laboratory

|July 12, 2023

概括

在手术后检测循环瘤细胞 (CTC) 显示乳腺癌没有直接的生存联系. 然而,患者的年龄和CTC测试的时间会影响结果,因此需要标准化程序来准确解释.

科学领域:

在瘤学瘤学.
生物标志物生物标志物
癌症的诊断癌症的诊断

背景情况:

晚期乳腺癌的预后很差,尽管在早期可以治愈.
早期发现乳腺癌可以通过及时治疗改善患者的生存率.
检测循环瘤细胞 (CTC) 提供了一种不那么侵入性的诊断方法.

研究的目的:

为了评估CTC在乳腺癌患者手术后的预后意义.
分析CTC数量与临床结果之间的相关性.

主要方法:

在经过手术后的乳腺癌患者中检测到CTC.
分析了CTC数量与患者存活率 (整体和无进展) 之间的关系.

主要成果:

在总CTC计数和总体或无进展生存时间之间没有发现显著的相关性.
在60岁以上的患者中观察到较高的CTC计数.
手术后CTC检测的时间显著影响了CTC计数.

结论:

标准化CTC测试程序,特别是时间,对于准确的结果解释至关重要.
在分析CTC数据时,必须考虑患者年龄等临床因素.
需要进一步的研究来完善CTC检测及其在乳腺癌管理中的临床应用.

更多相关视频

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment

Published on: May 14, 2019

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

相关概念视频

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...